期刊文献+

瑞士乳杆菌菌体的分离以及对小鼠肠道粘膜SIgA影响的研究 被引量:7

STUDY ON THE INFLUENCE OF SIGA IN THE GUT OF MICE AFTER IMMUNED LACTOBACILLUS HELVETICUS AND BACTERIAL ISOLATION
下载PDF
导出
摘要 首先利用离心的方法获得了瑞士乳杆菌TS206菌体,作出了600nm下瑞士乳杆菌TS206的菌落数和OD值关系曲线,然后利用不同的菌浓组(107、108、109、1010、1011cfu/mL)以及生理盐水对照组和大肠杆菌对照组(109cfu/mL)灌喂0.2mL,分别在第3、5、7、10、15天利用放射性免疫法(RIA)检测小鼠肠粘膜中SIgA含量。结果发现,高剂量组(109、1010组)的在中期SIgA含量开始有所升高但是到后期下降(P>0.05),和对照组没有显著性差异;其余各组与对照组相比P<0.05,故存在显著性差异,所以灌喂瑞士乳杆菌TS206对于SIgA含量的影响是显著的,在一定程度上反映了瑞士乳杆菌对小鼠肠道粘膜免疫的调节作用。实验同时得出最适剂量为108cfu/mL的菌悬液灌喂0.2mL和最佳耐受时间为10d。 In this experiment we used the method of centrifugation to obtain Lactobacillus helveticus TS206, and then made carve between bacteria number and OD value with A600. Adjusted different density of bacteria (10^7, 10^8, 10^9, 10^10, 10^11 cfu/mL) and control group with saline or E.coli (10^9 cfu/mL)instead, they received 0.2 mL, also the normal group mice fed like before. Killed the mice at 3, 5, 7, 10, 15 d at the same time and used radiate immunoassay (RIA) to determinate SIgA in the gut. The correlation analysis showed that there was significant correlation between SIgA and the density of bacteria, high dose(10^9,10^10 group) were little higher than normal and low dose to improve content of SIgA at metaphage but decrease at anaphase(P〉0.05), had no difference compared with control group. Other groups compared with control groups were all P〈0.05, so they were had notable difference. We have a conclusion is that take Lactobacillus helveticus orally can improve content of SIgA, by some means it reflects that Lactobacillus helveticus TS206 is able to improve mice's intestinal mucosa immune. With this study we find the appropriate dose is 0.2 mL(10^8 cfu/mL) and the best tolerance time is 10 days.
出处 《食品研究与开发》 CAS 北大核心 2008年第5期50-53,共4页 Food Research and Development
关键词 瑞士乳杆菌 OD值 小鼠 SIGA Lactobacillus helveticus OD value mice SIgA
  • 相关文献

参考文献9

  • 1Gleeson M, Cripps AW. Development of mucosal immunity in the first year of life and relationship to sudden infant death syndrome[J]. FEMS Immunol. Med. Microbiol, 2004,42(1):21-23
  • 2Perdigon G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system[J]. Curr. Issues Intest. Microbiol, 2001, 2(1):27
  • 3Rhee K J, Sethupathi P, Driks A, et al. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire[J]. Immunol, 2004,172(2): 1118-1124
  • 4Alvarez S, Gobbato N, Bru E, et al. Specific immunity induction at mucosal level by viable Lactobacillus casei. Perspective for oral vaccine development[J]. Food Agric. Immunol, 1998,10:79-87
  • 5Vintini E, Alvarez S, Medina M, et al. Gut mucosal immunostimulation by lactic acid bacteria[J]. Biocell, 2000, 23(3):223
  • 6DeSimone C, Tzantzoglou S, Baldinelli Let al.Ehancement of host resistanceagainst Salmonellatyphimufi um infectionby a diet supplement with yogurt[J]. Immunopharmacol Immunotoxical,1988,10(3):399-415
  • 7Perdigon G, Alvarez S, Nader-de-Macias-M E, et al. The oral administration of lactic acid bacteria increase the mucosal intestinal immunity in response to enteropathogens [J]. Journal of Food Protection, 1990, 53(5): 404-410
  • 8郭宇星,陈庆森,赵林森,杨晓威.瑞士乳杆菌发酵法制备乳清蛋白源性ACE抑制肽的研究[J].食品科学,2006,27(6):151-154. 被引量:14
  • 9Ricci G, Fortina MG. Characterization of Lactobacillus helvetlcus strains isolated from cheeses by distribution studies of insertion sequenees. International Journal of Food Microbiology [J].2006,112 ( 1): 112-119

二级参考文献9

  • 1Anne Pihlanto-Leppa la.Bioactive peptides derived from bovine whey proteins:opioid and ace-inhibitory peptides[J].Trends in Food Science and Technology,2001,11:347-356.
  • 2Pierre-Louis Leclerc.Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus[J].International Dairy Journal,2002,12:955-1004.
  • 3Yamamoto N,Akino A,Takano T.Purification and specificity of a cellwall associated proteinase from Lactobacillus helveticus CP790[J].Journal of Biochemistry,1993,114:740-745.
  • 4Yamamoto N,Maeno M,Takano T.Purification and characterization of an antihypertensive peptide froma yogurt-like product fermented by Lactobacillus helveticus CPN4[J].Journal of Dairy Science,1999,82:1388-1393.
  • 5Mullally M M,Meisel H,FitzGerald R J.Synthetic peptides corresponding to α-lactalbumin and β-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity[J].Biological Chemistry Hoppe-Seyler,1996,377:259-260.
  • 6M A F Belem,B F Gibbs,B H Lee.Proposing sequences for peptides derived from whey fermentation with protential bioactive sites[J].Journal of Dairy Science,1999,82(3):486-493.
  • 7Blanca Hernandez-Ledesma,Lourdes Amigo,Mercedes Ramos,et al.Application of high-performance liquid chromatography-tandem mass spectrometry to the identification of biologically active peptides produc ed by milk fermentation and simulated gastrointestinal digestion[J].Journal of chromatogramphy A,2004,1049:107-114.
  • 8VanessaVermeirssen,Arie van der Bent,John Van Camp.A quantitative in silico analysis calculates the angiotensin I converting enzyme (ACE)inhibitory activity in pea and whey protein digests[J].Biochimie,2004,86:231-239.
  • 9许庆陵,曾庆祝,崔铁军,赵惠,邢殿楼.鲢头酶解物对ACE的抑制活性[J].大连水产学院学报,2004,19(2):87-91. 被引量:16

共引文献13

同被引文献49

引证文献7

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部